MedTrace Logo

Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

NCT01105325 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2010-10-04

No results posted yet for this study

Summary

To study compliance with secondary prevention during the first months following discharge from the cardiac intensive care unit (CIC) of patients experiencing a first episode of acute coronary syndrome : quantitative compliance over 3 months with the two principal treatments of the prescription (a statin - rosuvastatin, Crestor® and a platelet aggregation inhibitor - clopidogrel, Plavix®), using an electronic measure system ("intelligent blister" pack®);

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Pascal Piedbois · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01105325 on ClinicalTrials.gov